tailieunhanh - A randomized phase II study of radiation induced immune boost in operable nonsmall cell lung cancer (RadImmune trial)

Lung cancer is the leading cause of cancer deaths worldwide. Surgery, radiotherapy at conventional and high dose and chemotherapy are the mainstay for lung cancer treatment. Insufficient migration and activation of tumour specific effector T cells seem to be important reasons for inadequate host anti-tumour immune response. |

TÀI LIỆU LIÊN QUAN
TỪ KHÓA LIÊN QUAN